Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Worek

Showing results (31-40 of 226) with videos related to

Pageof 23
Sort By:
Toxicology Letters|February 7, 2016
Kinetic analysis of interactions of amodiaquine with human cholinesterases and organophosphorus compoundsAnne Bierwisch, Timo Wille, Horst Thiermann, et al.
Chemico-Biological Interactions|July 26, 2012
Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximesFranz Worek, Timo Wille, Marianne Koller, et al.
Analytical and Bioanalytical Chemistry|February 1, 2025
Phosphonylated tyrosine and cysteine disulfide adducts both generated from immunoglobulin G and human serum albumin indicate exposure to the nerve agent VX in vitroHenrik Reuter, Dirk Steinritz, Franz Worek, et al.
Cell Stress & Chaperones|November 25, 2023
Recombinant cellular model system for human muscle-type nicotinic acetylcholine receptor α1<sub>2</sub>β1δεSabrina Brockmöller, Thomas Seeger, Franz Worek, et al.
Toxicology Letters|May 28, 2023
A pharmacologically pre-contracted smooth muscle bowel model for the study of highly-potent opioid receptor agonists and antagonistsNiko Amend, Horst Thiermann, Franz Worek, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 3, 2014
Adaptation of a dynamic in vitro model with real-time determination of butyrylcholinesterase activity in the presence of cyclosarin and an oximeFranz Worek, Gabriele Horn, Timo Wille, et al.
Toxicology|May 8, 2016
Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokineticsFranz Worek, Marianne Koller, Horst Thiermann, et al.
Rapid Communications in Mass Spectrometry : RCM|August 5, 2016
Modification of human serum albumin by the nerve agent VX: microbore liquid chromatography/electrospray ionization high-resolution time-of-flight tandem mass spectrometry method for detection of phosphonylated tyrosine and novel cysteine containing disulfide adductsAndreas Kranawetvogl, Franz Worek, Horst Thiermann, et al.
Biochemical Pharmacology|June 20, 2006
Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compoundsSaskia Eckert, Peter Eyer, Harald Mückter, et al.
Archives of Toxicology|June 29, 2016
Toxicology of organophosphorus compounds in view of an increasing terrorist threatFranz Worek, Timo Wille, Marianne Koller, et al.
Pageof 23

Showing results (31-40 of 226) with videos related to

Sort By:
Pageof 23
Toxicology Letters|February 7, 2016
Kinetic analysis of interactions of amodiaquine with human cholinesterases and organophosphorus compoundsAnne Bierwisch, Timo Wille, Horst Thiermann, et al.
Chemico-Biological Interactions|July 26, 2012
Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximesFranz Worek, Timo Wille, Marianne Koller, et al.
Analytical and Bioanalytical Chemistry|February 1, 2025
Phosphonylated tyrosine and cysteine disulfide adducts both generated from immunoglobulin G and human serum albumin indicate exposure to the nerve agent VX in vitroHenrik Reuter, Dirk Steinritz, Franz Worek, et al.
Cell Stress & Chaperones|November 25, 2023
Recombinant cellular model system for human muscle-type nicotinic acetylcholine receptor α1<sub>2</sub>β1δεSabrina Brockmöller, Thomas Seeger, Franz Worek, et al.
Toxicology Letters|May 28, 2023
A pharmacologically pre-contracted smooth muscle bowel model for the study of highly-potent opioid receptor agonists and antagonistsNiko Amend, Horst Thiermann, Franz Worek, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 3, 2014
Adaptation of a dynamic in vitro model with real-time determination of butyrylcholinesterase activity in the presence of cyclosarin and an oximeFranz Worek, Gabriele Horn, Timo Wille, et al.
Toxicology|May 8, 2016
Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokineticsFranz Worek, Marianne Koller, Horst Thiermann, et al.
Rapid Communications in Mass Spectrometry : RCM|August 5, 2016
Modification of human serum albumin by the nerve agent VX: microbore liquid chromatography/electrospray ionization high-resolution time-of-flight tandem mass spectrometry method for detection of phosphonylated tyrosine and novel cysteine containing disulfide adductsAndreas Kranawetvogl, Franz Worek, Horst Thiermann, et al.
Biochemical Pharmacology|June 20, 2006
Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compoundsSaskia Eckert, Peter Eyer, Harald Mückter, et al.
Archives of Toxicology|June 29, 2016
Toxicology of organophosphorus compounds in view of an increasing terrorist threatFranz Worek, Timo Wille, Marianne Koller, et al.
Pageof 23